Por: Associated Press Health June 06, 2023
Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivalent to extortion.The drugmaker is seeking to halt the program, which was laid out in the and is expected to save taxpayers billions of dollars in the coming years.Merck said in a complaint filed Tuesday that the program does not involve genuine negotiation. Instead, it said the U.S. Department of Health and Human Services... + full article
Los Angeles Times USA Business June 07, 2023
Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivalent to extortion. The drugmaker is seeking to halt the program, which was laid out in the Inflation Reduction Act and is expected to save taxpayers billions of... + más
'Frustration' fuels Broncos' sideline blowup in loss | ESPN
Did Martha Washington really name a cat after Alexander Hamilton? | The Boston Globe
CBS News USA Business June 07, 2023
Drugmaker Merck is suing the U.S. government over its plan to allow Medicare to negotiate prices for a handful of drugs, calling it extortion.The plan, part of the 2022 , is expected to save taxpayers on common drugs the government pays for. The law directs the Center for... + más
Merck sues U.S., calling Biden move to cut drug prices ‘extortion’ | Portland Press Herald
Merck sues over law empowering Medicare to negotiate with drug makers | The Boston Globe
The Boston Globe USA Business June 06, 2023
The pharmaceutical company Merck on Tuesday sued the government over a federal law that empowers Medicare for the first time to negotiate prices directly with drug makers.Merck’s lawsuit, filed in federal court in Washington, is the drug industry’s most significant move so... + más
Merck Tops Quarterly Profit Estimates but Sees Weaker 2023 Revenue on Lagevrio Sales Drop | MarketWatch
Politico USA Health June 06, 2023
Pharmaceutical giant Merck to block Medicare drug price negotiations, calling the program unconstitutional. The complaint, filed against the Department of Health and Human Services and the Centers for Medicare and Medicaid Services, argued that Medicare’s efforts to negotiate... + más
ABC News USA Health June 06, 2023
Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivalent to extortion.The drugmaker is seeking to halt the program, which was laid out in the Inflation Reduction Act and is expected to save taxpayers billions of... + más
Column: Merck says it's being 'coerced' into negotiating its drug prices with Medicare. That's nonsense | Los Angeles Times
Portland Press Herald USA World June 06, 2023
This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. AP Photo/Seth Wenig, File Merck is suing the U.S. over a law that will allow the government to negotiate prescription-drug prices with pharmaceutical companies — a reform aimed at cutting costs... + más
European committee: Regulators should deny Merck's Lagevrio | Associated Press
MarketWatch USA Business February 02, 2023
The company is expecting revenue to drop in 2023 amid a decline in sales of Lagevrio, its Covid-19 antiviral, and on Thursday set earnings guidance that was well below Wall Street expectations. Still, Merck Chief Financial Officer Caroline Litchfield said that the company’s... + más
Merck, Moderna detail potential skin cancer vaccine progress | WPLG Local 10
Merck, Moderna detail potential skin cancer vaccine progress | ABC News
About iurex | Privacy Policy | Disclaimer |